Skip to content
ppharmaranks
Menu
Class IIOngoing

LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per sachet, Di… recall

FDA recall D-0073-2025 · initiated Oct 8, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Dec 4, 2024How we research

Neogen Corporation recalled LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per… in Oct 2024 — an FDA Class II recall (D-0073-2025) because CGMP violations.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP violations.

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot LO09530; Exp 9/5/2025

Quantity recalled: 5,328 sachets

Details

Product
LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per sachet, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53427-124-01
Recalling company
Neogen Corporation
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.
Initiated
Oct 8, 2024
FDA report date
Dec 4, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per… recalled?
Neogen Corporation recalled LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per… in Oct 2024 — an FDA Class II recall (D-0073-2025) because CGMP violations. May cause temporary or medically reversible harm; low probability of serious harm.
Why was LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per… recalled?
Per the FDA enforcement record, the reason for recall D-0073-2025 was: CGMP violations.
Is a recalled LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per… dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per… are affected?
Distributed: Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.. The recall covers these lots — Lot LO09530; Exp 9/5/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0073-2025.

Source: openFDA Drug Enforcement record D-0073-2025

← All drug recalls